Back
Protagonist Therapeutics Vs. TD Synnex Industry Stock Comparison
Buy
54
PTGX
Protagonist Therapeutics
Last Price:
34.63
Seasonality Move:
-0.18%
Sell
36
SNX
TD Synnex
Last Price:
115.41
Seasonality Move:
2.11%
Buy
54
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $31.88. The Score for PTGX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
36
TD Synnex (SNX)
is a Sell
Is TD Synnex a Buy, Sell or Hold?
- The current TD Synnex [SNX] share price is $115.54. The Score for SNX is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- SNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $31.88
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTGX is experiencing slight buying pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 52.09 | Buy |
| Chaikin Money Flow: | 170898 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29.7 - 33.76) | Buy |
| Bollinger Bands (100): | (26.5 - 31.52) | Buy |
SNX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.22 | Sell |
| Relative Strength Index (14 RSI): | 26.95 | Sell |
| Chaikin Money Flow: | -663293 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (123.73 - 132.87) | Sell |
| Bollinger Bands (100): | (104.58 - 125.86) | Buy |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.01 | Sell |
| 20-day SMA: | 32.14 | Sell |
| 50-day SMA: | 29.56 | Buy |
| 200-day SMA: | 24.09 | Buy |
| 8-day EMA: | 32.1 | Sell |
| 20-day EMA: | 31.88 | Sell |
| 50-day EMA: | 30.45 | Buy |
| 200-day EMA: | 25.93 | Buy |
SNX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 125.4 | Sell |
| 20-day SMA: | 128.03 | Sell |
| 50-day SMA: | 123.99 | Sell |
| 200-day SMA: | 107.56 | Buy |
| 8-day EMA: | 122.79 | Sell |
| 20-day EMA: | 125.86 | Sell |
| 50-day EMA: | 123.43 | Sell |
| 200-day EMA: | 111.08 | Buy |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
TD Synnex Earnings Growth & SNX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.35 per share, an increase next quarter of $0.38 per share, an increase this year of $0.96 per share, and an increase next year of $1.19 per share.
Protagonist Therapeutics Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
TD Synnex Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||